If an AI writes the preliminary report, does a pathologist still have to look at the slide? A lab worker asked this online after a pathologist at another site signed out biopsies without seeing the slides. One reply: "An extremely relevant question in the age of AI." Others pointed to inspections: a qualified pathologist signs out the case, with peer review behind it. My answer: a signature means someone looked. An AI preliminary report can change the order of the work, not who is responsible for it. #AIInPathology #HumanOversight #PatientSafetyFirst

61.2% of request forms had no contact number. So who gets the critical value? In a study of 2,550 forms, 151 critical results came with incomplete ward information, and 19.9% of those were never phoned. Picture the night tech holding a potassium of 6.4, a form that says only "Ward 4," and no name to ask for. The lab cannot call faster than the form allows, so every order needs a reachable name and number. #CriticalResults #PatientSafety #LabMedicine

ONE RARE OVARIAN TUMOR. TWO DIFFERENT DIAGNOSES. WHICH ONE IS RIGHT? A 34-year-old woman with an 8 cm ovarian mass. Initially diagnosed as Sertoli–Leydig cell tumor. International pathology review later favored juvenile granulosa cell tumor (JGCT). But this was NO textbook JGCT! Under the microscope, TWO striking patterns: Solid, densely cellular lobules with irregular follicles, variable-sized cystic spaces and eosinophilic secretions. Loose spindle-cell, fibrovascular and thecomatous-appearing areas, with focal tubular-like structures mimicking Sertoli–Leydig differentiation. Even the immunostains were confusing, showing unexpected heterogeneous staining patterns! Yet no convincing separate Sertoli–Leydig component was identified in our reviewed sections. THE PATHOLOGY PEARL: Two morphological patterns do NOT necessarily mean two different tumors. Juvenile granulosa cell tumors can have many faces. And distinguishing these rare tumors matters—because diagnosis influences staging, treatment decisions, fertility preservation and long-term follow-up. Sometimes morphology must solve the mystery that immunohistochemistry creates. #Pathology #OvarianTumor #GranulosaCellTumor #Histopathology

The most trusted call a nurse ever got from the lab: "I dropped your sample." In a nursing thread with more than 3,500 upvotes, that was the top comment. A lab tech called to say the tube was dropped and spilled, and the nurse respected the truth far more than any excuse. In our hospital, tubes travel through the pneumatic system in dedicated lab capsules, and a misrouted or late capsule can still ruin a specimen. Trust grows when the lab says where a failure happened, even when the answer is the lab. #TransparencyBuildsTrust #LabLife #PatientSafety

CAN INTEROPERABILITY KILL A PATIENT? A glucometer. A network failure. 48 hours of missing results. One dangerous insulin decision. This is a REAL patient safety story. At a major hospital, bedside glucometers continued testing normally, but a disrupted TCP/IP interface silently stopped transmitting results. For TWO DAYS, glucose results accumulated. Then IT restarted the connection. Suddenly, 48 hours of historical results flooded into the clinical system — appearing with current timestamps! An old HIGH glucose result was mistaken for a new one. Additional insulin was administered. Emergency glucose treatment was needed to protect the patient. The analyzer was RIGHT. The result was RIGHT. The timing was WRONG. And that changed everything. We spend millions on analyzers, middleware, LIS and AI. But who owns the invisible journey between the analyzer and the clinician? A correct result delivered at the wrong time can become a dangerous result. This is why I’m writing my upcoming book: LAB BLACK BOXES Real stories. Hidden interfaces. Middleware failures. Patient safety. Practical solutions. It’s time to OPEN THE BLACK BOXES! Because there is no trustworthy clinical AI without trustworthy interoperability. #LabBlackBoxes #PatientSafety #Interoperability #LaboratoryMedicine #POCT #HealthcareAI

Your first mistake in the lab is a map, not a verdict. A blood bank tech posted online after being called into the QA office over a workup from the week before: an AB patient with an extra reaction on the reverse A cells. "I'm so embarrassed." A miss in the lab usually passes several steps before anyone sees it: the bench, the review, the second check. Each of those steps is a place to fix. My rule: replace blame with a process fix within 24 hours, and share the change. #LabQualityImprovement #BloodBankSafety #LaboratoryLeadership

Can a pyogenic granuloma really grow on a vocal cord? That was the whole question behind this second-opinion request. A 35-year-old man with a progressive change in his voice. A lesion on the true vocal cord. The original diagnosis: pyogenic granuloma. Under the microscope it was classic: lobules of thin-walled capillaries, edematous stroma, no dysplasia. It is rare in that place, yet the vocal cord's constant vibration and rich small vessels make it fertile ground for this reactive lesion. #RareMedicalCases #VoiceDisorders #DiagnosticPathology The diagnosis was right. The location was what needed a second look.

What happens to a CK of 97,000 before anyone sees it: • the analyzer flags it above its measuring range • the sample is diluted, run again, and the result multiplied back • if it is still too high, it is diluted again, up to a limit the lab director set • beyond that limit, the report says "greater than," never a guessed number One story shared online had exactly this: a CK of about 97,000 after a boxing camp, diluted three times before the lab could report it. Every step takes time, and none of it is the lab being slow. #BehindTheLabResults #CreatineKinase #LabMedicine

HIRSCHSPRUNG DISEASE: ONE WRONG BIOPSY. ONE WRONG DIAGNOSIS. A CHILD’S FUTURE AT STAKE. Where to biopsy? How deep? Where are the ganglion cells? 5 critical pathology pearls: Biopsy ≥2 cm above the dentate line. Adequate SUBMUCOSA is essential. Muscularis mucosae alone is NOT enough. Muscularis propria is NOT routinely required. H&E + calretinin; S100/SOX10 can highlight nerves. The dilemma? Proving that ganglion cells are ABSENT. In Hirschsprung disease, biopsy adequacy is patient safety. #HirschsprungDisease #Pathology

AI is only as clinically intelligent as the data we feed it. When a consumer AI health tool was tested on 960 cases, it sent 52% of true emergencies to a check within 24 to 48 hours instead of the emergency department. Among them was diabetic ketoacidosis, a condition defined by glucose, ketones and blood acidity. Those are numbers a typed description of symptoms does not contain. #AIInHealthcare #PatientSafety #LaboratoryMedicine

In 1,000 women co-tested in our lab, 72% of the HPV genotype-positive cases carried only non-16/18 high-risk types. Only 28% had HPV 16 or 18. Yet most screening and vaccine conversations start, and often end, with 16 and 18. Local data should shape who we screen and how we explain the result. #HPVAwareness #CervicalCancerScreening #LaboratoryMedicine

Everyone checks the diagnosis. Few check whose tissue it is. One study did what most labs never do: it tested almost 13,000 prostate biopsies to confirm the tissue belonged to the patient on the label. 0.26% were complete switches between patients. Another 0.67% contained tissue from a second patient. None had been suspected beforehand. A correct reading of the wrong patient's tissue is still a wrong diagnosis. #RightDiagnosisWrongPatient #PatientSafety #SpecimenIdentification #Pathology

What if AUTOIMMUNITY is not simply the immune system attacking SELF… but the immune system losing its ability to TRUST? We have spent decades teaching autoimmunity as “SELF vs NON-SELF.” But that’s only ONE face of a much bigger story. Autoimmunity has MANY faces: 🧬 Sometimes the immune system LEARNS the wrong lesson. 🧠 Sometimes it FORGETS what it once tolerated. 🔬 Sometimes it DISCOVERS antigens it was never exposed to before. Different mechanisms. Different triggers. Different patients. But one concept connects them all: IMMUNE TOLERANCE. In our culture, we have a beautiful concept: حُسن الظن (Husn Al-Dhann) Giving others the benefit of the doubt. Not assuming everyone is an enemy. A healthy immune system does something remarkably similar. Every second, it encounters thousands of signals. And its greatest achievement isn’t always deciding what to ATTACK. It’s knowing what to LEAVE ALONE. Regulatory T cells (Tregs) help maintain that delicate balance. Because not every antigen is a threat. Not every immune response is protective. And not every battle needs to be fought. When tolerance breaks, autoimmunity can emerge. Perhaps the most important question in autoimmunity isn’t WHY the immune system attacks… It’s WHY it stopped tolerating. And perhaps the greatest intelligence of our immune system is not its ability to fight, but its wisdom to know when NOT to fight. #Autoimmunity #Immunology #ImmuneTolerance

What a real sign-off is built on: • good care broken into observable behaviors • training on those behaviors • an audit of real encounters • the same measures, checked again When our phlebotomy patient-experience scores dropped, that is what we did: 100 real encounters, 41 measures. Professional self-introduction went from 20% to 75%. Time on the bench is not competence. #TimeIsNotCompetence #BeyondTheBench #CompetencyMatters #Phlebotomy

A patient's blood type changed. The lab was right. After a bone marrow transplant from a donor with a different blood group, the patient's red cells gradually switch to the donor's type. For a while, typing shows both. That is the donor marrow taking over, not an error. A blood bank tech shared exactly this online, and colleagues replied that it was a good sign: the graft was doing its job. Until it settles, every transfusion has to suit both blood types. #BloodTypeChanged #NotALabError #BoneMarrowTransplant #StemCellTransplant

The analyzer found a hemoglobin variant while running an A1C. Should the report say so? Some A1C methods separate hemoglobins and flag variants nobody asked about. Some variants can also make certain A1C methods read wrong. Labs handle it differently: a report comment, a call to the clinician, or a referral for confirmation. Lab colleagues: what does your lab do? #BeyondTheA1C #UnexpectedLabFindings #HemoglobinVariants

We’ve been teaching autoimmunity as “SELF vs NON-SELF.” But what if that’s only one face of the disease? Autoimmunity is far more complex. The immune system doesn’t just attack the wrong target. Sometimes, it: 🧬 LEARNS the wrong lesson. 🧠 FORGETS what it once tolerated. 🔬 DISCOVERS antigens it was never meant to encounter. Three different paths. One outcome: loss of immune tolerance. And here’s the fascinating part: The same trigger can cause devastating disease in one person and absolutely nothing in another. That’s why autoimmunity isn’t simply about recognizing SELF. It’s about learning, memory, exposure, and above all, TOLERANCE. Maybe the biggest question in autoimmunity isn’t WHY the immune system attacks. It’s WHY it stopped tolerating. #Autoimmunity #Immunology #ImmuneTolerance

Which tells you more: a result outside the range, or a result far from the patient's own last one? A reference range compares you with a population. A delta check compares you with yourself. A creatinine inside the range can still be a big jump for that patient. A hemoglobin steady all week that suddenly jumps today raises the real question: is the patient sicker, or is this someone else's blood? Often the best reference is the patient's own history.